European equities traded in the US as American depositary receipts were edging 0.03% lower late Friday morning to 1,298.5 on the S&P Europe Select ADR Index, which is up nearly 3% for the week.
From continental Europe, the gainers were led by biotech firm Evaxion Biotech (EVAX) and biopharmaceutical company DBV Technologies (DBVT), which climbed 14.7% and 5.4% respectively. They were followed by medical device maker EDAP TMS (EDAP) and biopharmaceutical company Cellectis (CLLS), which increased 4.3% and 4% respectively.
The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and biopharmaceutical company Grifols (GRFS), which shed nearly 15% and 5% respectively. They were followed by internet browser company Opera (OPRA) and 3D printer company Materialise (MTLS), which dropped 2.6% and 2.7% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical companies NuCana (NCNA) and TC Biopharm (TCBP), which rose 6% and 1.7% respectively. They were followed by medical device maker Smith & Nephew (SNN) and oil and gas company Shell (SHEL), which were up 1.4% and 1.1% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and biotech firm Autolus Therapeutics (AUTL), which fell 7% and 4.1% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group (MREO) and biotech firm Trinity Biotech (TRIB), which were each down 2.6%.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。